Characterization of two novel σ receptor ligands: antidystonic effects in rats suggest σ receptor antagonism

European Journal of Pharmacology

Volumn 280, Issue 3, 1995, Pages 301-310

  Matsumoto, Rae R ^a   Bowen, Wayne D ^b   Tom, Michael A ^a   Vo, Van Nhi ^a   Truong, Daniel D ^a   De Costa, Brian R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

DTG (di o tolylguanidine); Dystonia; Haloperidol; Red nucleus; Receptor

Indexed keywords

1 [2 (3,4 DICHLOROPHENYL)ETHYL] 4 METHYLPIPERAZINE; 1,3 BIS(2 METHYLPHENYL)GUANIDINE; BD 1063; CLONIDINE; CYCLAZOCINE; DEXTRALLORPHAN; DIHYDROALPRENOLOL; ETORPHINE; HALOPERIDOL; KETANSERIN; LEVALLORPHAN; MIANSERIN; N [2 (2,3 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; N [2 (3,4 DICHLOROPHENYL]ETHYL] N METHYL 2 (DIMETHYLAMINO)ETHYLAMINE; NEUROTRANSMITTER RECEPTOR; PARGYLINE; PENTAZOCINE; PIRENZEPINE; PRAZOSIN; PROPRANOLOL; QUINUCLIDINYL BENZILATE; RADIOLIGAND; RECEPTOR SUBTYPE; SEROTONIN; SIGMA 1 OPIATE RECEPTOR; SIGMA 2 OPIATE RECEPTOR; SIGMA OPIATE RECEPTOR; SIGMA OPIATE RECEPTOR LIGAND; SULPIRIDE; TENOCYCLIDINE; UNCLASSIFIED DRUG; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BINDING COMPETITION; CONTROLLED STUDY; DRUG ANTAGONISM; DYSTONIA; HISTOLOGY; INTRACEREBRAL DRUG ADMINISTRATION; LIGAND BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RED NUCLEUS;

ANIMAL; ANTICONVULSANTS; BEHAVIOR, ANIMAL; BINDING, COMPETITIVE; BRAIN; COMPARATIVE STUDY; DISEASE MODELS, ANIMAL; DYSTONIA; ETHYLENEDIAMINES; GUANIDINES; LIGANDS; MALE; PIPERAZINES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SIGMA; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029053594     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00208-3     Document Type: Article

References (52)

1. Modification of the N-methyl-d-aspartate response by antidepressant σ receptor ligands
2. 3H]-(+)-Pentazocine: a potent and highly selective benzomorphan-based probe for sigma-1 receptors
3. Metabolites of haloperidol display preferential activity at sigma receptors compared to dopamine D-2 receptors
4. Inhibition of the cholinergic phosphoinositide response by sigma ligands: distinguishing a sigma receptor-mediated mechanism from a mechanism involving direct cholinergic antagonism
5. Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)cyclohexylamine (BD737 and BD738): novel compounds with high affinity, selectivity, and biological efficacy at sigma receptors
6. Sigma receptor-mediated morphological and cytotoxic effects on primary culture of rat central and peripheral nervous system
7. 2 subtypes of dopamine receptors in brain
8. Sigma receptors inhibit contractions of the guinea pig ileum longitudinal muscle/myenteric plexus preparation elicited by both electrical stimulation and exogenous serotonin
9. Adrenergic receptors in frontal cortex of human brain
10. Activation of the A10 mesolimbic system by the σ-receptor agonist (+)SKF10,047 can be blocked by rimcazole, a novel putative antipscyhotic
11. Focal stimulation of specific pathways in the rat hippocampus causes a reduction in radioligand binding to the haloperidol-sensitive sigma receptor
12. Is the haloperidol-sensitive sigma binding site a receptor for an endogenous neurotransmitter?
13. An endogenous ligand for the sigma opioid binding site
14. Characterization of novel agents for sigma receptor agonist and antagonist activity in modulation of the muscarinic phosphoinositide response
15. 3H]-(+)-pentazocine, a highly potent and selective radioligand for sigma receptors
16. Synthesis, characterization, and biological evaluation of a novel class of N-(arylethyl)-N-alkyl-2-(1-pyrrolidinyl)ethylamines: structural requirements and binding affinity at the sigma receptor
17. Synthesis and evaluation of conformationally restricted N-[2-(34-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamines at sigma receptors II Piperazines bicyclic amines bridged bicyclic amines and miscellaneous compounds
18. Antagonism of a (+)N-allylnormetazocine stimulus by (−)PPAP and several structurally related analogs
19. 3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine
20. 2 receptors: characterization by ligand binding and photoaffinity labeling
21. 3H]ketanserin
22. Sigma inhibition of the cholingergic phosphoinositide response: characterization of partial agonists and antagonists at sigma-1 receptors
23. Autoradiography of adrenoceptors in rat and human brain: α-adrenoceptor and idazoxan binding sites
24. Solubilization and characterization of sigma-receptors from guinea pig membranes
25. 2 binding in rat brain
26. Protein measurement with the Folin phenol reagent
27. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain
28. Age-related differences in the sensitivity of rats to a selective sigma ligand
29. Drug specificity of pharmacological dystonia
30. A novel sigma binding site that may negatively modulate excitatory amino acid neurotransmission
31. 3H]SKF-10,047 binding sites (sigma sites) from rat liver membranes
32. Autoradiographic visualization of haloperidol-sensitive sigma receptors in guinea-pig brain
33. In vivo electrophysiological evidence for a selective modulation of N-methyl-d-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands
34. Effect of paroxetine, a selective 5-hydroxytryptamine uptake inhibitor, on β-adrenoceptors in rat brain: autoradiographic and functional studies
35. 3H]-prazosin in the rat cerebral cortex
36. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors
37. Phencyclidine (angel dust)/sigma ‘opiate’ receptor: visualization by tritium-sensitive film
38. A proposal for the classification of sigma binding sites
39. Purification and partial amino acid sequence of a 28 kDa cyclophilin-like component of the rat liver sigma receptor
40. Further evidence of phencyclidine/sigma opioid receptor commonality
41. Further characterization of an endogenous ligand (‘sigmaphin’) for sigma receptors in the brain
42. Endogenous ligands for sigma opioid receptors in the brain (‘sigmaphin’): evidence from binding assays
43. 3H]haloperidol binding in guinea pig brain membranes
44. Guinea-pig vas deferens preparation may contain both sigma and phencyclidine receptors
45. Cytotoxic effects of sigma ligands: sigma receptor-mediated alterations in cellular morphology and viability
46. Evidence for a role of haloperidol-sensitive sigma-‘opiate’ receptors in the motor side effects of antipsychotic drugs
47. Sigma receptors: biology and function
48. 2 receptors in motor function
49. 3H]tolyl)guanidine: a selective ligand that labels σ-type receptors for psychotomimetic opiates and antipsychotic drugs
50. Effects of the selective sigma receptor ligand, 6-[6-(4-hydroxypiperidinyl)hexyloxy]-3-methylflavone (NPC 16377), on behavioral and toxic effects of cocaine
51. Electrophysiological and binding studies on intact NCB-20 cells suggest presence of a low affinity sigma receptor